Transforming Tomorrow
By Solving Global Microbial Challenges
Imagine a world where surfaces are self-sanitizing, where the materials around us actively protect our health.
Imagine a world where surfaces are self-sanitizing, where the materials around us actively protect our health, and where innovation is woven into the fabric of our daily lives. This is the vision that drives us at Frida Group.
We are not just creating a product; we are fostering a movement towards a safer, healthier future.
At Frida Group, we are dedicated to solving global microbial challenges through proactive and sustainable antimicrobial solutions. Founded in 2021, Frida is at the forefront of combating microbes across broad industries and addressing the rising threat of antimicrobial resistance (AMR).
Our proprietary technology, Crystalitic®, is created from patented catalytic crystals that integrate seamlessly into various materials and surfaces, rendering them self-sanitizing. By protecting against microbial threats, Crystalitic® extends product lifespan while offering a safer, non-toxic and long-lasting alternative to traditional antimicrobials like silver. This pioneering technology is designed to combat a range of microbial challenges while combatting antimicrobial resistance and creating positive ecological impact.
Every crystal within Crystalitic® is a beacon of our commitment to excellence. Our technology ensures that wherever Crystalitic® is applied, it delivers superior antimicrobial protection.
We believe in empowering industries to elevate their products, transforming the ordinary into the extraordinary.
At Frida Group, we’re Solving Global Microbial Challenges with Crystalitic® – join us in creating a safer, healthier future for all.
At Frida Group we build collaborative partnerships with our clients
Our team
Sales, Strategy and Marketing
Lars Bang Pedersen
Klaus Aamann
Claus Gernsøe Jørgensen
Gert Olsen
Ina Ahrensberg
Product & Compliance
Henrik Bang
Auguste Hinrichs
Ameya Jagtap
Edgar Snoeck
Mathilde Lassen Witt
How it all began
Prof. Dr. J. Peter Guggenbichler, a renowned pediatrician, inventor, and co-founder of Frida Group, has dedicated his career to improving patient care and public health. With decades of research and medical practice, he has become a pioneer in modern antimicrobial technology. Driven by his deep understanding of the critical need for safe and clean environments, Dr. Guggenbichler invented the antimicrobial technology behind Crystalitic®. Today, he continues to serve as a trusted scientific advisor, guiding Frida Group’s commitment to proactively prevent infectious diseases and combat antimicrobial resistance.